Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank50
3Y CAGR+45.4%
5Y CAGR+6.4%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+45.4%/yr
vs -19.5%/yr prior
5Y CAGR
+6.4%/yr
Recent acceleration
Acceleration
+64.9pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 55.92 | +63.1% |
| 2023 | 34.28 | +151.7% |
| 2022 | 13.62 | -25.1% |
| 2021 | 18.19 | +100.2% |
| 2020 | -8787.78 | -21536.8% |
| 2019 | 40.99 | -66.7% |
| 2018 | 122.99 | +184.0% |
| 2017 | 43.31 | -46.2% |
| 2016 | 80.47 | +145.2% |
| 2015 | 32.82 | - |